Evidence map›Paper›PMID 31032187›Full record

ArticleQuantitative imaging in medicine and surgery2019

Prognostic value of pre-treatment CT texture analysis in combination with change in size of the primary tumor in response to induction chemotherapy for HPV-positive oropharyngeal squamous cell carcinoma.

Tamari A Miller, Kayla R Robinson, Hui Li, Tanguy Y Seiwert, Daniel J Haraf, Li Lan, Maryellen L Giger, Daniel T Ginat

Open access · diamondAbstract read
In one paragraph

Article in Quantitative imaging in medicine and surgery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Observational
  4. Review
  5. Review
  6. Article
  7. Application of radiomics and machine learning in head and neck cancers.International journal of biological sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Tamari A Miller1Pritzker School of Medicine, 2Department of Radiology, 3Section of Hematology-Oncology, Department of Medicine, 4Department of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL 60637, USA.
Kayla R Robinson1Pritzker School of Medicine, 2Department of Radiology, 3Section of Hematology-Oncology, Department of Medicine, 4Department of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL 60637, USA.
Hui Li1Pritzker School of Medicine, 2Department of Radiology, 3Section of Hematology-Oncology, Department of Medicine, 4Department of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL 60637, USA.
Tanguy Y Seiwert1Pritzker School of Medicine, 2Department of Radiology, 3Section of Hematology-Oncology, Department of Medicine, 4Department of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL 60637, USA.
Daniel J Haraf1Pritzker School of Medicine, 2Department of Radiology, 3Section of Hematology-Oncology, Department of Medicine, 4Department of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL 60637, USA.
Li Lan1Pritzker School of Medicine, 2Department of Radiology, 3Section of Hematology-Oncology, Department of Medicine, 4Department of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL 60637, USA.
Maryellen L Giger1Pritzker School of Medicine, 2Department of Radiology, 3Section of Hematology-Oncology, Department of Medicine, 4Department of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL 60637, USA.
Daniel T Ginat1Pritzker School of Medicine, 2Department of Radiology, 3Section of Hematology-Oncology, Department of Medicine, 4Department of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL 60637, USA.
University of Chicago · US

Funding

RESEARCH TRAINING IN MEDICAL PHYSICST32EB002103 · NIBIB · UNIVERSITY OF CHICAGO · PI ARMATO, SAMUEL G. · 2003 to 2019
$4.7M
NIBIB NIH HHS T32 EB002103
6 · The paper itself

Abstract

backgroundTo determine the additive value of quantitative radiomic texture features in predicting progression in human papillomavirus (HPV)-positive oropharyngeal squamous cell carcinoma (OPSCC) based on pre-treatment CT.

methodsRetrospective analysis of a single-center cohort of adult patients enrolled in a response-adapted radiation volume de-escalation trial treated with induction chemotherapy. Texture analysis of HPV-positive OPSCC was performed via primary tumor site contouring on pre-treatment contrast-enhanced CT scans. Percent change in size of the tumor in response to induction chemotherapy based on RECIST 1.1 criteria and progression free survival were clinically determined for this cohort. Receiver operating characteristic (ROC) analysis was performed to compare the accuracy of percent change in tumor size after induction chemotherapy with a combination of change in tumor size and radiomic texture features for predicting tumor progression.

resultsRadiomic texture analysis of the primary tumors in 38 patients with OPSCC depicted on pre-treatment neck CT scans using skewness and entropy in combination with percent change in tumor size after induction chemotherapy yielded a statistically significant increase in accuracy for predicting tumor progression over change in tumor size alone, with an area under the curve of 0.80 versus 0.56 (one-tailed P=0.0087).

conclusionsThis pilot study suggests that disease progression in patients with HPV-positive OPSCC is more accurately predicted using a combination of texture features on pre-treatment CT scans, along with change in tumor size compared to change in tumor size alone and could therefore serve as a radiomic texture signature.

Indexed as

cancerComputerized tomography (CT)oropharyngealsizetexture analysis

Identifiers

PMID31032187
PMCPMC6462569
OpenAlexW2921843919

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.